Serum resistin level: As a predictor of atrial fibrillation after coronary artery bypass graft surgery

Coronary Artery Disease

Volumn 22, Issue 7, 2011, Pages 484-490

  Gungor, Hasan ^a   Ayik, Mehmet Fatih ^b   Kirilmaz, Bahadir ^c   Ertugay, Serkan ^b   Gul, Ilker ^b   Yildiz, Bekir Serhat ^b   Nalbantgil, Sanem ^b   Zoghi, Mehdi ^b  

^a Mus State Hospital   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

atrial fibrillation; coronary artery bypass graft surgery; inflammation; resistin

Indexed keywords

RESISTIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HORMONE BLOOD LEVEL; HUMAN; INTENSIVE CARE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RESISTIN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TURKEY; UP-REGULATION;

EID: 80053622062     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834b67bb     Document Type: Article

References (33)

1. Patel D, Gillinov MA, Natale A. Atrial fibrillation after cardiac surgery: where are we now? Indian Pacing Electrophysiol J 2008; 8:281-291.
2. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-1729. (Pubitemid 38489894)
3. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135:1061-1073. (Pubitemid 33151027)
4. Magee MJ, Herbert MA, Dewey TM, Edgerton JR, Ryan WH, Prince S, et al. Atrial fibrillation after coronary artery by-pass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg 2007; 83:1707-1712. (Pubitemid 46621120)
5. Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg 2009; 88:326-333.
6. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312. (Pubitemid 32151228)
7. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255:439-447. (Pubitemid 38446357)
8. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19:4046-4055. (Pubitemid 30608543)
9. Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 2006; 3:29-34.
10. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276:11252-11256. (Pubitemid 38089312)
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96:1180-1184. (Pubitemid 27344221)
12. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79:1530-1535. (Pubitemid 40614561)
13. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104:2886-2891. (Pubitemid 33139098)
14. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006-3010. (Pubitemid 37553570)
15. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005; 95:764-767. (Pubitemid 40340139)
16. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, Van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96:3542-3548. (Pubitemid 27513431)
17. Cosgrave J, Foley JB, Flavin R, O'briain DS, Fitzpatrick E, Bennett K, et al. Preoperative atrial histological changes are not associated with postoperative atrial fibrillation. Cardiovasc Pathol 2006; 15:213-217. (Pubitemid 44038393)
18. Kawahito K, Kobayashi E, Ohmori M, Harada K, Kitoh Y, Fujimura A, et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs 2000; 24:37-42. (Pubitemid 30186720)
19. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. Eur J Cardiothorac Surg 2002; 21:232-244. (Pubitemid 34135370)
20. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004; 93:1176-1178. (Pubitemid 38521055)
21. Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006; 20:51-56. (Pubitemid 43182777)
22. Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005; 101:17-23. (Pubitemid 40853342)
23. Canbaz S, Erbas H, Huseyin S, Duran E. The role of inflammation in atrial fibrillation following open heart surgery. J Int Med Res 2008; 36:1070-1076.
24. Ucar HI, Tok M, Atalar E, Dogan OF, Oc M, Farsak B, et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 2007; 10:131-135.
25. Czerny M, Baumer H, Kilo J, Zuckermann A, Grubhofer G, Chevtchik O, et al. Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 2001; 71:165-169. (Pubitemid 32102653)
26. Rubens FD, Nathan H, Labow R, Williams KS, Wozny D, Karsh J, et al. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 2005; 79:655-665. (Pubitemid 40186577)
27. Pascual DA, Arribas JM, Tornel PL, Marín F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg 2006; 81:78-83. (Pubitemid 41815377)
28. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114:1455-1461. (Pubitemid 44526999)
29. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes 2005; 29:1315-1320. (Pubitemid 41679262)
30. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004; 27:2450-2457. (Pubitemid 39281400)
31. Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol 2005; 4:10.
32. Stejskal D, Adamovská S, Bartek J, Juráková R, Prosková J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147:63-69.
33. Harsch IA, Koebnick C, Wallaschofski H, Schahin SP, Hahn EG, Ficker JH, et al. Resistin levels in patients with obstructive sleep apnoea syndrome: the link to subclinical inflammation? Med Sci Monit 2004; 10:510-515.